— Know what they know.
Not Investment Advice
Also trades as: COLO-B.CO (CPH) · $vol 22M · CBHD.DE (XETRA) · $vol 0M · CLPBF (OTC) · $vol 0M

CLPBY OTC

Coloplast A/S
1W: -4.3% 1M: -16.5% 3M: +1.3% YTD: -26.2% 1Y: -28.4% 3Y: -36.9% 5Y: -59.0%
$6.18
-0.08 (-1.28%)
 
Weekly Expected Move ±2.6%
$6 $6 $6 $6 $7
OTC · Healthcare · Medical - Instruments & Supplies · Tech Score Strong Sell · Power 32 · $13.9B mcap · 143M float · 0.239% daily turnover · Short 34% of daily vol

Analyst Insights

Wall Street analyst consensus based on price targets and buy/sell/hold recommendations from institutional research coverage over the trailing 12 months.

Analyst Price Targets
$7
Low
$7
Avg Target
$7
High
Based on 1 analyst since Aug 18, 2026 earnings
Analyst Recommendations
Strong Buy: 0Buy: 3Hold: 3Sell: 2Strong Sell: 0
Rating Summary
ConsensusBuy
Avg Target$7.38
Analysts1
Price Target Change History
DateFirmAnalystOldNewChangeUpside @ CallStock@Call
2026-09-11 Berenberg Bank — Initiated $7 — +12.3% $6.57
2025-04-25 Bernstein — Initiated $14 — +30.5% $11.07

Financial Rating

Composite financial health rating (A+ to F) based on discounted cash flow valuation, return on equity, return on assets, debt-to-equity leverage, and relative P/E and P/B multiples.

B+
Oct 02, 2026
DCF
4
ROE
5
ROA
5
D/E
1
P/E
2
P/B
1
The Financial Rating evaluates six fundamental factors — discounted cash flow (DCF) valuation, return on equity (ROE), return on assets (ROA), debt-to-equity leverage (D/E), and relative price-to-earnings (P/E) and price-to-book (P/B) multiples — each scored 1–5. CLPBY receives an overall rating of B+. Strongest factors: DCF (4/5), ROE (5/5), ROA (5/5). Areas of concern: D/E (1/5), P/E (2/5), P/B (1/5).
Rating Change History
DateFromTo
2026-10-01 B B+
2026-08-19 B- B
2026-06-15 B B-
2026-06-04 B- B
2026-06-02 B B-
2026-05-13 B+ B
2026-05-11 B B+
2026-05-08 B+ B
2026-05-07 B B+
2026-04-17 B+ B

InsiderStreet Scorecard

Proprietary multi-factor scorecard rating companies across seven fundamental dimensions — profitability, balance sheet strength, earnings quality, growth, value, momentum, and safety — each scored 0–100.

★ ★ ★ ★ ★ — Grade B
Profitability
72
Balance Sheet
47
Earnings Quality
60
Growth
20
Value
—
Momentum
53
Safety
—
Cash Flow
76

Risk & Quality Signals

Academic financial models used by institutional investors to assess bankruptcy risk, earnings manipulation, financial strength, and credit quality.

Altman Z-Score
—
—
Piotroski F-Score
5/9
✓ ✓ ✗ ✓ ✗ ✓ ✓ ✗ ✗
Beneish M-Score
-3.04
Unlikely Manipulator
Ohlson O-Score
-7.53
Bankruptcy prob: 0.1%
Low Risk
Credit Rating
A-
Score: 67.6/100
Trend: Improving
Earnings Quality
75/100
OCF/NI: 2.81x
Accruals: -10.5%
The Piotroski F-Score (2000) is a 9-point binary checklist — four profitability tests (positive ROA, positive cash flow, improving ROA, cash flow exceeding net income), three leverage tests (declining debt ratio, improving current ratio, no share dilution), and two efficiency tests (improving gross margin, improving asset turnover). Each pass scores 1 point. CLPBY scores 5/9, indicating moderate financial health — some areas of strength offset by weaknesses in others. The Beneish M-Score (1999) is an 8-variable model that detects earnings manipulation by comparing year-over-year changes in receivables, gross margins, asset quality, sales growth, depreciation, SG&A, leverage, and accruals. Scores above −1.78 statistically resemble past manipulators. CLPBY's score of -3.04 falls below this threshold, suggesting earnings are unlikely to be manipulated. The Ohlson O-Score (1980) is a 9-variable logistic regression that estimates bankruptcy probability using firm size, leverage, working capital, current ratio, profitability (ROA), cash flow coverage, negative equity flag, consecutive losses flag, and earnings trajectory. The raw score is converted to a probability via logistic transformation. CLPBY's implied 0.1% bankruptcy probability is well within safe territory. Our Credit Rating model scores companies on five weighted components — solvency (30%), earning power (25%), leverage (20%), liquidity (15%), and cash flow quality (10%) — then blends the absolute score with sector and industry peer rankings. For companies with large buyback programs, equity is adjusted by adding back cumulative 5-year repurchases (capped at 80% of FCF generated) to avoid penalizing shareholder-friendly capital allocation. CLPBY receives an estimated rating of A- (score: 67.6/100), with a improving trend. The Earnings Quality score measures how well reported earnings are backed by real cash. It evaluates the operating cash flow to net income ratio (OCF/NI ≥ 1.0 means every dollar of earnings is cash-backed) and the accruals ratio (the gap between earnings and cash flow relative to assets — lower is better). CLPBY's score of 75/100 is high — cash flows strongly support reported earnings.

Valuation

Key valuation multiples comparing the stock's market price to its earnings, revenue, book value, and cash flows. Lower multiples may indicate relative undervaluation versus peers.

P/E
33.65x
PEG
-1.04x
P/S
3.27x
P/B
6.95x
P/FCF
—
P/OCF
—
EV/EBITDA
—
EV/Revenue
—
EV/EBIT
—
EV/FCF
—
Earnings Yield
—
FCF Yield
—
Shareholder Yield
—
Graham Number
$12.78
Equity-based multiples (P/E, P/B, P/FCF) compare the stock price to per-share fundamentals and are affected by capital structure. Enterprise value multiples (EV/EBITDA, EV/Revenue, EV/FCF) strip out debt and cash, making them more useful for cross-company comparisons regardless of how companies are financed. The Graham Number — √(22.5 × EPS × Book Value) — is Benjamin Graham's formula for the maximum price a defensive investor should pay. At 33.6x earnings, CLPBY commands a growth premium. Graham's intrinsic value formula yields $12.78 per share, suggesting a potential 107% margin of safety at the current price.

DuPont Decomposition (5-Factor)

The 5-factor DuPont framework breaks Return on Equity into its component drivers — tax efficiency, interest burden, operating profitability, asset utilization, and financial leverage — to reveal what truly drives shareholder returns.

Tax Burden
0.759
NI / EBT
×
Interest Burden
0.487
EBT / EBIT
×
EBIT Margin
0.275
EBIT / Rev
×
Asset Turnover
0.571
Rev / Assets
×
Equity Multiplier
3.180
Assets / Equity
=
ROE
18.5%
The 5-factor DuPont identity decomposes ROE as: Tax Burden × Interest Burden × EBIT Margin × Asset Turnover × Equity Multiplier = ROE. This reveals whether returns are driven by operating performance, financial leverage, or tax efficiency — three very different sources of profitability. CLPBY's ROE of 18.5% is driven by financial leverage (equity multiplier: 3.18x). Note: high leverage means ROE is amplified by debt rather than operational performance.

Graham-Dodd Adjusted Valuation

Our adaptation of Graham's growth formula (Fair P/E = 8.5 + 2g) from The Intelligent Investor. The classic version relies on analyst growth projections, which can be unreliable. This adjusted model substitutes the company's realized 3-year EPS CAGR — a backward-looking, verifiable measure of actual earnings power — grounding the valuation in demonstrated performance rather than forecasts.

Two adjustments we make, and why. Growth is capped at 15%. Graham defined g as expected growth over the next seven to ten years, not last year's rate. Across US companies since 1994 the median realized 7-year EPS growth is 5–8% regardless of how fast a company grew beforehand, and of 4,457 company-quarters that grew faster than 200%, none sustained it. Uncapped, the formula assigned fair multiples in the hundreds to companies that had never held that rate — and scored worse than simply reading the P/E. Capped, it carries real information. The verdict has three states, not two. Tested over 377,249 stock-months, this ratio only separates outcomes at its extremes: below 0.25 beat the universe by 1.3 points a year, above 3.0 lagged by 2.7, and everything in between sat inside a one-point band. Rather than call two-thirds of the market "undervalued" on a threshold of 1.0, we say Neutral where the model cannot tell — which is most of the time.

Adj. Growth Rate
0.00%
Fair P/E
8.50x
Intrinsic Value
$10.40
Price/Value
—
Margin of Safety
—
Premium
—
Graham's classic formula uses analyst-projected growth to estimate a fair P/E (8.5 + 2g). Our adjusted version replaces that projection with CLPBY's realized 0.0% 3-year EPS CAGR, capped at 15% — demonstrated performance rather than forecasts, held to a rate companies have historically sustained. CLPBY trades at a premium to its adjusted intrinsic value of $10.40, suggesting the market is pricing in future growth beyond what historical earnings support. The adjusted fair P/E of 8.5x compares to the current market P/E of 33.6x.

Profitability Trends

Historical profitability ratios tracking how efficiently the company converts revenue into returns for shareholders over time.

Leverage & Solvency Trends

Debt and liquidity metrics showing the company's financial leverage and ability to meet short-term and long-term obligations.

Efficiency & Working Capital Trends

Operating efficiency metrics measuring how quickly the company converts inventory to sales, collects receivables, and manages its cash conversion cycle.

Growth Trends (YoY %)

Year-over-year growth rates for key financial metrics, showing the trajectory of revenue, earnings, and cash flow generation.

Earnings Stability

R-squared of linear regression measuring how predictably revenue, earnings, and margins follow a trend over the trailing 5 years. 1.0 = perfectly predictable; lower values indicate erratic or cyclical behavior.

Monte Carlo Price Simulation

Geometric Brownian Motion with 1,000 antithetic paths over 1 year, seeded from 1800 days of historical volatility. Percentile bands show the range of statistically plausible outcomes — this is a statistical model, not a forecast.

Current Price
$6.18
Median 1Y
$5.54
5th Pctile
$3.59
95th Pctile
$8.57
Ann. Volatility
27.9%
Analyst Target
$7.38
25th–75th percentile 5th–95th percentile Median path Historical Analyst target
All Ratios & Metrics

Complete fundamental data with up to 20 periods of history, sparkline trends, and current values across 13 categories and 130+ financial metrics.

Profitability
Metric Trend Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Q3'26 Current
ROE 62.0% 80.3% 66.8% 67.3% 57.2% 75.1% 67.1% 69.5% 37.4% 46.3% 42.7% 43.2% 28.7% 31.9% 27.4% 24.7% 21.3% 27.2% 13.9% 18.5% 18.49%
ROA 32.9% 31.5% 18.8% 18.9% 18.5% 18.0% 13.6% 13.6% 11.5% 11.6% 11.9% 11.9% 10.5% 10.1% 9.3% 8.4% 7.5% 8.2% 4.3% 5.8% 5.81%
ROIC 47.9% 47.2% 17.9% 18.7% 18.8% 18.7% 19.2% 19.5% 14.9% 15.1% 13.8% 15.9% 14.6% 14.0% 13.1% 12.4% 45.7% 46.5% 79.0% 70.9% 70.94%
ROCE 66.8% 83.3% 59.9% 24.1% 23.3% 26.0% 26.2% 26.5% 21.1% 23.2% 22.7% 19.7% 19.0% 20.9% 19.5% 19.8% 17.5% 17.9% 18.0% 18.5% 18.50%
Gross Margin 69.0% 68.3% 68.7% 69.2% 68.8% 67.9% 66.4% 65.9% 66.4% 68.2% 68.0% 67.5% 66.7% 67.6% 68.2% 67.6% 88.9% 66.6% 42.9% 66.7% 66.73%
Operating Margin 36.3% 31.2% 23.7% 29.8% 29.3% 28.8% 27.2% 28.1% 26.4% 27.6% 27.2% 27.0% 27.4% 27.2% 27.3% 26.3% 35.8% 26.3% 25.4% 25.9% 25.89%
Net Margin 25.6% 23.4% 17.8% 22.0% 20.3% 18.5% 19.1% 20.8% 19.7% 18.3% 19.0% 18.5% 18.9% 14.9% 13.2% 11.6% 16.3% 19.7% -13.7% 19.9% 19.88%
EBITDA Margin 36.3% 33.6% 28.9% 35.6% 32.4% 33.3% 32.0% 33.0% 32.0% 30.8% 32.3% 31.9% 30.6% 32.7% 31.0% 31.3% 40.6% 32.7% 72.6% 30.8% 30.82%
FCF Margin 17.1% 21.5% 18.1% 18.0% 17.6% 13.8% 15.2% 13.3% 12.2% 17.1% 4.1% 5.0% 5.4% 6.0% 17.7% 17.9% 20.0% 20.5% 22.8% 23.3% 23.34%
OCF Margin 27.2% 26.2% 22.9% 22.7% 22.6% 18.9% 20.3% 18.4% 17.2% 22.1% 8.9% 9.9% 10.2% 10.9% 22.6% 23.1% 25.4% 26.2% 28.7% 28.6% 28.60%
ROE 3Y Avg snapshot only 25.15%
ROE 5Y Avg snapshot only 42.98%
ROA 3Y Avg snapshot only 8.20%
ROIC 3Y Avg snapshot only 63.71%
ROIC Economic snapshot only 70.41%
Cash ROA snapshot only 16.49%
Cash ROIC snapshot only 21.30%
CROIC snapshot only 17.38%
NOPAT Margin snapshot only 95.29%
Pretax Margin snapshot only 13.41%
R&D / Revenue snapshot only 3.83%
SGA / Revenue snapshot only 39.40%
SBC / Revenue snapshot only 0.00%
Valuation
Metric Trend Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Q3'26 Current
P/E Ratio — — — — — — — — — — — — — — — — — — — — 33.646
P/S Ratio — — — — — — — — — — — — — — — — — — — — 3.268
P/B Ratio — — — — — — — — — — — — — — — — — — — — 6.955
P/FCF — — — — — — — — — — — — — — — — — — — — —
P/OCF — — — — — — — — — — — — — — — — — — — — —
EV/EBITDA — — — — — — — — — — — — — — — — — — — — —
EV/Revenue — — — — — — — — — — — — — — — — — — — — —
EV/EBIT — — — — — — — — — — — — — — — — — — — — —
EV/FCF — — — — — — — — — — — — — — — — — — — — —
Earnings Yield — — — — — — — — — — — — — — — — — — — — —
FCF Yield — — — — — — — — — — — — — — — — — — — — —
Graham Number snapshot only $12.78
Leverage & Solvency
Metric Trend Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Q3'26 Current
Current Ratio 1.11 0.86 0.33 1.01 1.20 0.89 0.99 0.98 0.61 0.53 0.60 0.85 1.02 0.81 0.95 1.00 1.61 1.30 1.75 1.56 1.561
Quick Ratio 0.72 0.56 0.21 0.66 0.76 0.56 0.62 0.62 0.39 0.35 0.39 0.56 0.66 0.52 0.61 0.64 1.00 0.81 1.09 0.94 0.941
Debt/Equity 0.34 0.78 2.90 2.83 2.26 3.76 3.08 3.41 1.13 1.43 1.51 1.18 1.26 1.60 1.43 1.47 1.40 1.82 1.89 1.78 1.781
Net Debt/Equity 0.26 0.65 2.80 2.71 2.18 3.61 2.99 3.28 1.08 1.37 1.46 1.13 1.22 1.54 1.39 1.43 1.35 1.74 1.80 1.72 1.720
Debt/Assets 0.18 0.31 0.60 0.59 0.54 0.63 0.61 0.63 0.41 0.45 0.51 0.40 0.47 0.51 0.49 0.51 0.47 0.51 0.52 0.51 0.507
Debt/EBITDA 0.39 0.70 3.00 2.84 2.54 2.89 2.70 2.78 2.45 2.71 3.00 2.34 2.66 2.83 2.76 2.76 2.58 2.85 2.04 1.98 1.982
Net Debt/EBITDA 0.29 0.58 2.90 2.72 2.45 2.78 2.62 2.67 2.34 2.60 2.89 2.23 2.57 2.72 2.68 2.68 2.47 2.73 1.95 1.91 1.914
Interest Coverage 212.17 221.59 63.96 27.90 20.45 14.91 11.37 11.41 9.83 9.38 9.96 8.91 8.66 8.65 7.63 6.03 6.15 6.35 7.54 10.94 10.943
Equity Multiplier 1.94 2.52 4.84 4.84 4.22 5.96 5.02 5.41 2.78 3.21 2.97 2.94 2.68 3.13 2.90 2.91 3.00 3.53 3.63 3.51 3.511
Cash Ratio snapshot only 0.123
Debt Service Coverage snapshot only 17.634
Cash to Debt snapshot only 0.034
FCF to Debt snapshot only 0.265
Defensive Interval snapshot only 214.3 days
Efficiency & Turnover
Metric Trend Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Q3'26 Current
Asset Turnover 1.32 1.28 0.82 0.85 0.89 0.91 0.68 0.69 0.59 0.60 0.61 0.63 0.56 0.57 0.57 0.58 0.54 0.54 0.55 0.57 0.571
Inventory Turnover 2.63 2.63 2.50 2.50 2.51 2.50 2.41 2.42 2.44 2.40 2.37 2.36 2.44 2.48 2.45 2.43 1.93 1.96 2.40 2.41 2.413
Receivables Turnover 6.32 6.48 6.10 6.20 6.31 6.56 6.31 6.15 5.94 5.99 5.92 5.91 6.01 6.10 5.92 5.79 5.62 5.77 5.68 5.72 5.725
Payables Turnover 6.61 10.72 9.70 9.93 6.19 9.44 8.13 8.40 6.44 7.82 7.10 7.58 6.23 7.80 7.41 7.63 5.15 6.41 7.21 7.49 7.487
DSO 58 56 60 59 58 56 58 59 61 61 62 62 61 60 62 63 65 63 64 64 63.8 days
DIO 139 139 146 146 145 146 152 151 150 152 154 155 150 147 149 150 189 186 152 151 151.2 days
DPO 55 34 38 37 59 39 45 43 57 47 51 48 59 47 49 48 71 57 51 49 48.8 days
Cash Conversion Cycle 141 161 168 168 144 163 165 167 155 166 164 168 152 160 161 166 183 192 165 166 166.3 days
Fixed Asset Turnover snapshot only 3.343
Operating Cycle snapshot only 194.1 days
Cash Velocity snapshot only 33.128
Capital Intensity snapshot only 1.734
Growth (YoY)
Metric Trend Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Q3'26 Current
Revenue 4.8% 6.9% 11.4% 14.3% 16.2% 18.4% 16.8% 12.5% 8.5% 6.3% 6.0% 8.1% 10.3% 9.8% 8.9% 5.9% -2.9% -4.3% -4.5% -2.9% -2.87%
Net Income 15.0% 15.4% 10.3% 4.8% -2.5% -5.5% 1.2% 0.1% 1.6% 5.2% 3.4% 3.8% 5.6% 0.3% -8.5% -18.0% -28.1% -18.6% -54.3% -32.4% -32.35%
EPS 14.9% 15.1% 10.4% 5.1% -2.4% -5.1% 1.5% 0.1% -3.8% 2.3% -2.2% -1.8% 5.5% -2.7% -8.8% -18.2% -28.2% -18.5% -54.3% -32.3% -32.34%
FCF -13.2% 42.3% 18.1% 25.5% 19.3% -24.0% -1.9% -17.2% -24.7% 32.0% -71.3% -59.3% -50.7% -61.3% 3.7% 2.8% 2.6% 2.3% 22.6% 26.4% 26.35%
EBITDA 7.6% 6.9% 4.1% 3.6% 2.9% 6.5% 14.2% 9.5% 8.2% 4.1% 1.9% 5.0% 6.4% 9.7% 7.5% 4.9% 3.6% 0.4% 35.3% 37.1% 37.11%
Op. Income 8.6% 8.7% 10.6% 8.9% 1.3% 2.3% 8.9% 6.0% 5.2% 3.8% 0.6% 3.1% 8.9% 9.3% 8.5% 6.0% 2.3% 0.2% -1.9% -0.2% -0.21%
OCF Growth snapshot only 20.44%
Asset Growth snapshot only -1.96%
Equity Growth snapshot only -18.73%
Debt Growth snapshot only -1.70%
Shares Change snapshot only -0.01%
Dividend Growth snapshot only 7.78%
Growth (CAGR)
Metric Trend Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Q3'26 Current
Revenue 3Y 5.7% 5.7% 6.2% 7.2% 8.0% 8.7% 8.7% 9.4% 9.7% 10.4% 11.3% 11.6% 11.6% 11.4% 10.5% 8.8% 5.2% 3.8% 3.3% 3.6% 3.61%
Revenue 5Y 5.8% 6.1% 6.5% 7.2% 7.8% 8.4% 8.7% 8.5% 8.3% 8.3% 8.2% 8.4% 8.5% 8.4% 8.2% 8.5% 7.2% 7.2% 7.5% 7.4% 7.43%
EPS 3Y 7.7% 7.8% 6.0% 5.1% 6.6% 5.3% 6.1% 6.7% 2.6% 3.8% 3.1% 1.1% -0.3% -1.9% -3.3% -7.0% -10.0% -6.7% -25.9% -18.4% -18.37%
EPS 5Y 8.8% 8.3% 7.6% 8.2% 4.3% 4.1% 4.9% 4.6% 3.3% 4.0% 3.4% 2.7% 4.2% 3.1% 1.3% -0.5% -4.0% -2.4% -14.5% -10.6% -10.57%
Net Income 3Y 7.9% 7.9% 5.9% 5.1% 6.7% 5.2% 6.1% 6.6% 4.5% 4.7% 4.9% 2.9% 1.5% -0.1% -1.4% -5.2% -8.3% -4.9% -24.4% -16.8% -16.79%
Net Income 5Y 9.0% 8.4% 7.7% 8.3% 4.4% 4.1% 4.9% 4.6% 4.5% 4.6% 4.4% 3.8% 5.5% 4.2% 2.5% 0.6% -2.8% -1.3% -13.6% -9.6% -9.58%
EBITDA 3Y 8.1% 7.6% 5.7% 5.9% 8.4% 8.6% 8.9% 8.7% 6.2% 5.8% 6.6% 6.0% 5.8% 6.7% 7.7% 6.5% 6.1% 4.7% 14.0% 14.7% 14.73%
EBITDA 5Y 9.0% 8.9% 7.9% 8.4% 5.4% 6.3% 7.5% 7.1% 7.1% 6.7% 6.5% 6.4% 7.9% 7.9% 7.2% 7.2% 5.7% 5.5% 12.0% 11.4% 11.37%
Gross Profit 3Y 6.4% 6.5% 7.0% 7.8% 8.5% 9.0% 8.7% 9.0% 9.0% 9.8% 10.8% 11.1% 11.1% 10.7% 9.8% 8.2% 6.8% 5.3% 1.7% 2.3% 2.31%
Gross Profit 5Y 5.8% 6.2% 6.6% 7.4% 8.0% 8.7% 8.8% 8.5% 8.1% 8.1% 8.2% 8.4% 8.5% 8.2% 8.0% 8.3% 8.5% 8.4% 6.5% 6.2% 6.23%
Op. Income 3Y 7.8% 7.5% 6.1% 5.8% 5.2% 4.9% 5.4% 5.7% 5.0% 4.9% 6.6% 6.0% 5.1% 5.1% 6.0% 5.0% 5.4% 4.4% 2.3% 2.9% 2.92%
Op. Income 5Y 5.7% 5.8% 5.2% 5.6% 5.1% 5.7% 7.0% 6.8% 6.0% 5.7% 5.5% 5.3% 5.9% 5.5% 5.1% 5.2% 5.2% 4.8% 5.2% 4.7% 4.72%
FCF 3Y -3.4% 6.6% 1.6% 2.7% 2.1% -5.8% -2.3% -6.4% -8.0% 12.6% -30.7% -24.9% -23.8% -27.0% 9.7% 8.7% 9.8% 18.5% 18.1% 25.1% 25.11%
FCF 5Y 6.9% 16.2% 15.6% 11.0% 9.1% 0.1% 1.7% -2.1% -4.2% 4.0% -21.6% -18.3% -16.9% -15.7% 4.6% 4.9% 6.5% 12.4% 13.8% 15.3% 15.29%
OCF 3Y 6.6% 8.1% 4.1% 5.7% 5.4% -1.2% 0.9% -2.5% -3.9% 3.8% -23.4% -19.7% -19.4% -16.9% 10.1% 9.4% 9.3% 15.5% 15.9% 20.0% 19.96%
OCF 5Y 11.8% 14.4% 13.6% 10.4% 9.4% 2.2% 3.5% 0.5% -0.6% 6.0% -11.4% -9.0% -8.7% -8.3% 5.7% 5.8% 7.0% 6.8% 8.4% 9.0% 9.04%
Assets 3Y 10.4% 10.1% 42.0% 41.0% 40.0% 38.6% 37.7% 38.1% 52.8% 48.2% 46.7% 46.5% 44.8% 44.0% 11.8% 10.8% 11.5% 11.5% 9.8% 10.2% 10.19%
Assets 5Y 7.6% 4.7% 23.0% 23.5% 23.7% 23.6% 22.6% 22.6% 32.6% 32.0% 31.4% 31.1% 30.4% 29.6% 29.4% 29.2% 29.1% 26.7% 25.1% 24.9% 24.88%
Equity 3Y 8.4% 7.3% 5.6% 7.0% 6.3% 2.7% 2.2% 0.7% 32.7% 37.9% 32.7% 33.6% 30.0% 34.0% 32.6% 31.2% 24.9% 32.7% 22.3% 27.2% 27.23%
Book Value 3Y 8.2% 7.2% 5.7% 7.0% 6.2% 2.8% 2.2% 0.8% 30.3% 36.7% 30.4% 31.3% 27.6% 31.6% 30.1% 28.7% 22.5% 30.2% 19.9% 24.8% 24.81%
Dividend 3Y 1.8% 1.8% 1.9% 1.8% 1.7% 1.8% 1.7% 1.8% -0.2% 2.2% 1.3% 1.8% 1.7% 0.2% 0.2% -0.3% 0.8% 0.4% 0.3% 0.6% 0.57%
Growth Quality
Metric Trend Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Q3'26 Current
Revenue Stability 0.99 0.98 0.94 0.94 0.92 0.89 0.88 0.92 0.94 0.92 0.92 0.94 0.94 0.94 0.96 0.99 0.92 0.88 0.86 0.87 0.873
Earnings Stability 0.87 0.90 0.94 0.90 0.84 0.82 0.94 0.86 0.84 0.82 0.94 0.84 0.82 0.71 0.50 0.06 0.04 0.02 0.33 0.50 0.503
Margin Stability 0.99 0.99 0.99 0.99 0.99 0.99 0.99 0.99 0.99 0.99 0.99 0.99 0.99 0.99 0.99 0.99 0.97 0.97 0.98 0.98 0.979
Rev. Growth Consistency 1.00 1.00 0.50 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 0.00 0.00 0.00 0.00 0.000
Earn. Growth Consistency 1.00 1.00 1.00 1.00 0.00 0.00 1.00 1.00 0.50 0.50 1.00 1.00 1.00 1.00 0.00 0.00 0.00 0.00 0.00 0.00 0.000
FCF Positive Streak 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1
Earnings Persistence 0.94 0.94 0.96 0.98 0.99 0.98 1.00 1.00 0.99 0.98 0.99 0.98 0.98 1.00 0.97 0.93 0.89 0.93 0.50 0.87 0.871
Earnings Smoothness 0.86 0.86 0.90 0.95 0.98 0.94 0.99 1.00 0.98 0.95 0.97 0.96 0.95 1.00 0.91 0.80 0.67 0.79 0.25 0.61 0.614
ROE Trend 0.03 0.03 0.04 0.02 -0.01 0.03 0.05 0.08 -0.30 -0.45 -0.36 -0.40 -0.14 -0.24 -0.23 -0.27 -0.05 -0.03 -0.13 -0.07 -0.068
Gross Margin Trend 0.01 0.01 0.01 0.01 0.01 0.00 -0.00 -0.01 -0.02 -0.02 -0.01 -0.01 -0.00 -0.00 -0.00 0.00 0.05 0.05 -0.02 -0.03 -0.028
FCF Margin Trend -0.04 0.03 -0.01 -0.01 -0.01 -0.05 -0.02 -0.04 -0.05 -0.01 -0.13 -0.11 -0.09 -0.09 0.08 0.09 0.11 0.09 0.12 0.12 0.119
Sustainable Growth Rate 12.8% 14.0% 9.9% 10.4% 8.1% 6.2% 7.7% 7.8% 4.2% 2.0% 2.7% 2.1% 1.9% -0.5% -2.5% -5.4% -8.7% -9.1% -21.7% -17.3% -17.35%
Internal Growth Rate 7.3% 5.8% 2.9% 3.0% 2.7% 1.5% 1.6% 1.6% 1.3% 0.5% 0.7% 0.6% 0.7% — — — — — — — —
Cash Flow Quality
Metric Trend Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Q3'26 Current
OCF/Net Income 1.10 1.06 0.99 1.03 1.08 0.96 1.02 0.94 0.88 1.14 0.46 0.52 0.55 0.61 1.38 1.58 1.84 1.73 3.67 2.81 2.809
FCF/OCF 0.63 0.82 0.79 0.79 0.78 0.73 0.75 0.72 0.71 0.78 0.46 0.51 0.53 0.56 0.78 0.78 0.79 0.79 0.79 0.82 0.816
FCF/Net Income snapshot only 2.292
OCF/EBITDA snapshot only 0.645
CapEx/Revenue 10.1% 4.7% 4.7% 4.7% 5.0% 5.1% 5.1% 5.2% 5.1% 5.0% 4.8% 4.9% 4.8% 4.8% 4.9% 5.1% 5.4% 5.6% 5.9% 5.3% 5.26%
CapEx/Depreciation snapshot only 0.313
Accruals Ratio -0.03 -0.02 0.00 -0.01 -0.02 0.01 -0.00 0.01 0.01 -0.02 0.06 0.06 0.05 0.04 -0.04 -0.05 -0.06 -0.06 -0.12 -0.11 -0.105
Sloan Accruals snapshot only -0.017
Cash Flow Adequacy snapshot only 1.144
Earnings Quality Score snapshot only 0.750
Dividends & Buybacks
Metric Trend Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Q3'26 Current
Dividend Yield — — — — — — — — — — — — — — — — — — — — 5.58%
Dividend/Share $1.80 $1.90 $1.90 $1.90 $1.90 $2.00 $2.00 $2.00 $1.89 $2.13 $2.07 $2.10 $2.10 $2.20 $2.20 $2.20 $2.27 $2.36 $2.35 $2.37 $2.30
Payout Ratio 79.4% 82.6% 85.2% 84.5% 85.9% 91.8% 88.5% 88.8% 88.8% 95.7% 93.8% 95.0% 93.4% 1.0% 1.1% 1.2% 1.4% 1.3% 2.6% 1.9% 1.94%
FCF Payout Ratio 1.2% 94.7% 1.1% 1.0% 1.0% 1.3% 1.2% 1.3% 1.4% 1.1% 4.4% 3.6% 3.2% 3.0% 1.0% 99.2% 97.4% 98.3% 87.9% 84.6% 84.57%
Total Payout Ratio 89.7% 92.8% 1.0% 99.8% 99.0% 1.1% 92.3% 89.8% 88.8% 95.7% 93.8% 95.0% 93.4% 1.0% 1.1% 1.2% 1.4% 1.3% 2.6% 1.9% 1.94%
Div. Increase Streak 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1
Chowder Number — — — — — — — — — — — — — — — — — — — — —
Buyback Yield — — — — — — — — — — — — — — — — — — — — —
Net Buyback Yield — — — — — — — — — — — — — — — — — — — — —
Total Shareholder Return — — — — — — — — — — — — — — — — — — — — —
DuPont Factors
Metric Trend Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Q3'26 Current
Tax Burden (NI/EBT) 0.77 0.78 0.78 0.78 0.77 0.77 0.78 0.78 0.79 0.79 0.79 0.79 0.79 0.74 0.70 0.66 0.63 0.68 0.68 0.76 0.759
Interest Burden (EBT/EBIT) 0.98 0.98 0.98 0.96 0.95 0.93 0.91 0.91 0.90 0.89 0.90 0.89 0.89 0.89 0.87 0.84 0.79 0.79 0.42 0.49 0.487
EBIT Margin 0.33 0.32 0.30 0.30 0.29 0.27 0.28 0.28 0.27 0.28 0.27 0.27 0.27 0.27 0.27 0.27 0.28 0.28 0.28 0.28 0.275
Asset Turnover 1.32 1.28 0.82 0.85 0.89 0.91 0.68 0.69 0.59 0.60 0.61 0.63 0.56 0.57 0.57 0.58 0.54 0.54 0.55 0.57 0.571
Equity Multiplier 1.88 2.55 3.55 3.57 3.09 4.17 4.93 5.11 3.25 3.99 3.59 3.64 2.73 3.17 2.94 2.93 2.83 3.32 3.22 3.18 3.180
Per Share
Metric Trend Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Q3'26 Current
EPS (Diluted TTM) $2.27 $2.30 $2.23 $2.25 $2.21 $2.18 $2.26 $2.25 $2.13 $2.23 $2.21 $2.21 $2.25 $2.17 $2.02 $1.81 $1.61 $1.77 $0.92 $1.22 $1.22
Book Value/Share $3.84 $3.01 $3.41 $3.42 $3.90 $2.78 $3.31 $3.05 $7.70 $6.92 $7.21 $7.35 $7.97 $6.86 $7.52 $7.30 $7.17 $6.14 $5.70 $5.93 $5.93
Tangible Book/Share $2.12 $1.29 $-6.54 $-6.28 $-5.63 $-6.54 $-5.92 $-5.81 $-6.21 $-7.47 $-6.32 $-6.25 $-5.51 $-6.74 $-6.33 $-5.98 $-6.09 $-7.28 $-6.50 $-6.20 $-6.20
Revenue/Share $9.12 $9.31 $9.67 $10.16 $10.62 $11.07 $11.33 $11.44 $10.91 $11.44 $11.36 $11.70 $12.01 $12.18 $12.33 $12.36 $11.65 $11.68 $11.78 $12.01 $12.62
FCF/Share $1.56 $2.00 $1.75 $1.83 $1.86 $1.53 $1.72 $1.52 $1.33 $1.96 $0.47 $0.58 $0.65 $0.74 $2.19 $2.22 $2.33 $2.40 $2.68 $2.80 $2.78
OCF/Share $2.48 $2.44 $2.21 $2.31 $2.40 $2.10 $2.30 $2.11 $1.88 $2.53 $1.01 $1.16 $1.23 $1.32 $2.79 $2.85 $2.96 $3.05 $3.38 $3.44 $3.41
Cash/Share $0.32 $0.41 $0.35 $0.40 $0.30 $0.41 $0.30 $0.40 $0.41 $0.42 $0.40 $0.39 $0.35 $0.40 $0.32 $0.32 $0.42 $0.50 $0.47 $0.36 $0.36
EBITDA/Share $3.37 $3.38 $3.30 $3.41 $3.47 $3.61 $3.77 $3.74 $3.55 $3.65 $3.64 $3.72 $3.77 $3.89 $3.90 $3.89 $3.90 $3.91 $5.27 $5.33 $5.33
Debt/Share $1.31 $2.36 $9.90 $9.68 $8.80 $10.45 $10.19 $10.40 $8.71 $9.90 $10.91 $8.69 $10.06 $10.99 $10.76 $10.74 $10.07 $11.15 $10.76 $10.56 $10.56
Net Debt/Share $0.99 $1.96 $9.55 $9.28 $8.50 $10.03 $9.89 $9.99 $8.30 $9.48 $10.51 $8.29 $9.71 $10.59 $10.44 $10.42 $9.64 $10.65 $10.29 $10.20 $10.20
Academic Models
Metric Trend Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Q3'26 Current
Altman Z-Score — — — — — — — — — — — — — — — — — — — — —
Piotroski F-Score 5 8 4 6 5 4 7 4 3 5 4 4 6 5 7 6 6 5 5 5 5
Beneish M-Score -2.43 -2.58 -1.65 -1.63 -1.69 -1.64 -2.42 -2.41 -2.21 -2.24 -1.98 -1.98 -2.20 -2.33 -2.56 -2.69 -2.85 -2.78 -2.84 -3.04 -3.036
Ohlson O-Score snapshot only -7.534
Net-Net WC snapshot only $-10.28
EVA snapshot only $22155854817.15
Credit
Metric Trend Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Q3'26 Current
Credit Rating snapshot only A-
Credit Score 81.75 80.25 56.30 61.70 64.70 57.85 57.85 57.85 55.30 55.90 50.80 56.35 57.70 55.35 59.35 58.20 63.30 59.75 64.80 67.60 67.600
Credit Grade snapshot only 7
Credit Trend snapshot only 9.400
Implied Spread (bps) snapshot only 175.000

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms